OTCMKTS:OCPNY - OLYMPUS Corp/S Stock Price, News, & Analysis

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices. The company also provides upright, polarizing, inverted, laser scanning confocal, stereo, and marco fluorescence microscopes; box-type fluorescence imaging devices, microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes; microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes and ancillary equipment, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, binoculars, and related software applications; and biomedical materials system. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

OLYMPUS Corp/S (OTCMKTS:OCPNY) Frequently Asked Questions

What is OLYMPUS Corp/S's stock symbol?

OLYMPUS Corp/S trades on the OTCMKTS under the ticker symbol "OCPNY."

How were OLYMPUS Corp/S's earnings last quarter?

OLYMPUS Corp/S (OTCMKTS:OCPNY) released its earnings results on Friday, May, 11th. The company reported $0.24 earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by $0.08. The company had revenue of $1.98 billion for the quarter, compared to the consensus estimate of $1.97 billion. OLYMPUS Corp/S had a net margin of 2.65% and a return on equity of 4.84%. View OLYMPUS Corp/S's Earnings History.

When is OLYMPUS Corp/S's next earnings date?

OLYMPUS Corp/S is scheduled to release their next quarterly earnings announcement on Friday, February 8th 2019. View Earnings Estimates for OLYMPUS Corp/S.

Has OLYMPUS Corp/S been receiving favorable news coverage?

Headlines about OCPNY stock have trended somewhat positive this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. OLYMPUS Corp/S earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are some of OLYMPUS Corp/S's key competitors?

Some companies that are related to OLYMPUS Corp/S include 21st North (ULGX), 22nd Century Group (XXII), 3D Signatures (DXD), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abaxis (ABAX), Abcam (ABC), ABCAM PLC/ADR (ABCZY), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acerus Pharmaceuticals (ASP), Acrux (ACR) and Actinium Pharmaceuticals (ATNM).

Who are OLYMPUS Corp/S's key executives?

OLYMPUS Corp/S's management team includes the folowing people:

• Mr. Hiroyuki Sasa, Pres & Representative Director (Age 63)
• Mr. Yasuo Takeuchi, VP, CFO, Chief Regional Representative Officer & Director (Age 61)
• Mr. Haruo Ogawa, Sr. Exec. Managing Officer, CTO, Head of R&D Group & Director (Age 61)
• Mr. Kiichi Hirata, Exec. Managing Officer, Chief Admin. Officer & Director (Age 61)
• Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel

How do I buy shares of OLYMPUS Corp/S?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OLYMPUS Corp/S's stock price today?

One share of OCPNY stock can currently be purchased for approximately $31.5450.

What is OLYMPUS Corp/S's official website?

The official website for OLYMPUS Corp/S is http://www.olympus-global.com.

How can I contact OLYMPUS Corp/S?

OLYMPUS Corp/S's mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2427 or via email at [email protected]